share_log

特宝生物:关于派格宾增加适应症拟纳入优先审评程序的自愿性披露公告

Xiamen Amoytop Biotech: Voluntary disclosure notice on the proposed inclusion of additional indications for Pegobin in the priority review process

Sensex a share ·  May 7
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more